Passez à l'illimité avec Magzter GOLD

Passez à l'illimité avec Magzter GOLD

Obtenez un accès illimité à plus de 9 000 magazines, journaux et articles Premium pour seulement

$149.99
 
$74.99/Année

Essayer OR - Gratuit

A tiny hedge fund is becoming a thorn in the side of energy giant BP

Mint Mumbai

|

February 15, 2024

London-based Bluebell Capital Partners aims at big targets via campaigns against world’s biggest cos, sometimes hitting them

-  Jenny Strasburg

A tiny hedge fund is becoming a thorn in the side of energy giant BP

Giuseppe Bivona and his partners run a tiny activist hedge fund from a small office here not far from Buckingham Palace. The single room has big windows, seven desks and little space for much else.

From this unlikely perch, the fund, called Bluebell Capital Partners, aims to punch far above its weight by launching campaigns against some of the world’s biggest companies, most of them in Europe. Sometimes the punches land.

The fund’s latest target, British oil giant BP, has already granted Bivona a meeting with its chairman, according to people familiar with the meeting. And BP’s new chief executive officer, Murray Auchincloss, last week was compelled to refute Bluebell’s arguments when announcing the company’s otherwise rosy earnings report.

That might seem an outsize response to a fund that has accumulated a holding likely worth less than 0.01% of BP’s roughly $103 billion market capitalization, based on Bluebell’s general description of its portfolio. Bluebell declined to disclose its exact investment.

Bluebell’s criticism could resonate because it taps into a core challenge facing BP: its commitment to shrinking oil-and-gas production while boosting investment in less-profitable green-energy sources.

Meanwhile many investors, including Bluebell, simply want more of BP’s cash to be handed back to them.

In his opening salvo to BP, a letter sent in October, Bivona called the plan to invest more in clean energy at the expense of oil-and-gas production “irrational." Bivona argues that doing so in effect strengthens competitors such as Shell, Exxon Mobil and Chevron, which aren’t setting short-term targets to dial back on drilling.

“You only make richer the shareholders of your competitor," said Bivona in an interview. “I’m questioning how they deploy capital, for sure. Big time."

PLUS D'HISTOIRES DE Mint Mumbai

Mint Mumbai

Mint Mumbai

Tobacco cess set to expire, enter health and national security cess

Finance minister Nirmala Sitharaman will introduce a bill in Lok Sabha on Monday to levy a new cess for public health and national security, replacing the GST compensation cess on tobacco, which will lapse when the Centre completes repayment of the loans raised to compensate states.

time to read

2 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

Battery PLI may get new spark as rules set to ease

Scheme saw limited success; 50GWh capacity by Dec 2024 goal fell far short

time to read

3 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

China used to be a cash cow for western companies. Now it’s a test lab.

For Western companies in China, a new reality has set in: The easy money is gone and competition is only getting fiercer.

time to read

4 mins

December 01, 2025

Mint Mumbai

BEHIND THE GLOSSY REPORT: THE MAKE BELIEVE ESG WORLD

Recently, the Sebi chairperson made a distinction that should make every company board squirm, Speaking at the “Gatekeepers of Governance’ summit, Tuhin Kanta Pandey separated “compliance” from “governance” in a way that was both elegant and damning.

time to read

2 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

New safety, emission rules spell riches for parts firms

Anti-lock brakes? Sound alerts for EVs? Ever-changing emission norms? For India’s nimble auto parts makers, every new regulation to raise safety and lower pollution is opening up business avenues.

time to read

3 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

APIs to innovation: Bulk drug makers ramp up CDMO bets

Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.

time to read

2 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

Smart GDP growth casts shadow over December rate cut

The Reserve Bank of India’s (RBI's) Monetary Policy Committee (MPC) is widely expected to keep the policy rate unchanged on 5 December, even as a sizable minority of economists argues that the space created by softening inflation and moderating nominal growth warrants another rate cut.

time to read

2 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

Why MF vendors haven't grown as fast as MF assets

A rising tide does not lift all boats—an adage that mutual fund distributors will vouch for.

time to read

4 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

Gen Alpha will make new rules for their workplace

Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’

time to read

3 mins

December 01, 2025

Mint Mumbai

EC extends electoral roll revision by a week to II Dec; final list on 14 Feb

The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.

time to read

2 mins

December 01, 2025

Listen

Translate

Share

-
+

Change font size